EMERGENCY DEPARTMENT PRESENTATION AND CARE OF HEART AND HEART - LUNG-TRANSPLANT RECIPIENTS

被引:16
作者
STERNBACH, GL
VARON, J
HUNT, SA
机构
[1] Department of Surgery, Emergency Medicine Service, Stanford University Medical Center, Stanford, CA
[2] Department of Medicine, Stanford University Medical Center, Stanford, CA
[3] Post-Cardiac Transplant Service, Stanford University Medical Center, Stanford, CA
关键词
HEART TRANSPLANTATION; HEART LUNG TRANSPLANTATION;
D O I
10.1016/S0196-0644(05)80661-4
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Study objective: Heart and heart/lung transplants are accepted forms of therapy for patients with end-stage cardiac or pulmonary disease. These patients are likely to present postoperatively to the emergency department. To our knowledge, there have been no previous reports in the medical literature of the ED presentation of these patients. Design: We conducted a retrospective review of the records of all patients who had received a heart or a heart/lung transplant at Stanford University Medical Center from 1988 through 1990 and who had at least one ED visit. Measurements and results: Between the time of operation and April 1, 1991, 131 ED visits were recorded. Fever was the single most common presenting complaint, for 48 (37%) of the visits. Difficulty in breathing (13%); gastrointestinal symptoms of nausea, vomiting, or diarrhea (10%); and chest pain (9%) were other common reasons for presentation. Conclusion: The transplant patient, by virtue of requiring chronic immunosuppression, is susceptible to infection with a spectrum of opportunistic organisms. When fever or other symptoms suggest infection, appropriate cultures and aggressive diagnostic procedures (eg, lumbar puncture, bronchoscopy) should be performed.
引用
收藏
页码:1140 / 1144
页数:5
相关论文
共 17 条
[1]  
Samuelsson, Hunt, Schroeder, Functional and social rehabilitation of heart-transplant recipients under age thirty, ScandJ Thorac Cardiovasc Surg, 18, pp. 97-103, (1984)
[2]  
Evans, Manniene, Maier, Et al., The quality of life of kidney- and heart-transplant recipients, Transplant Proc, 17, pp. 1579-1582, (1985)
[3]  
Hunt, Schroeder, Managing patients after cardiac transplantation, Hosp Pract, 24, pp. 83-100, (1989)
[4]  
Burke, Theodore, Baldwin, Et al., Twenty-eight cases of human heart-lung transplantation, Lancet, 1, pp. 517-519, (1986)
[5]  
Kniett, Kaye, The registry of the International Society for Heart Transplantation: Seventh official report—1990, J Heart Lung Transplant, 9, pp. 323-330, (1990)
[6]  
Hutter, Scott, Wreghitt, Et al., The importance of cytomegalovirus in heart-lung transplant recipients, Chest, 95, pp. 627-631, (1989)
[7]  
Burke, Glanville, Macoviak, Et al., The spectrum of cytomegalovirus infection following human heart-lung transplantation, J Heart Transplant, 5, pp. 267-272, (1986)
[8]  
Grossi, Revello, Minoli, Et al., Three-year experience with human cytomegalovirus infections in heart transplant recipients, J Heart Transplant, 9, pp. 712-719, (1990)
[9]  
Dajani, Bisno, Chung, Et al., Prevention of bacterial endocarditis, Recommendations of the American Heart Association, 264, pp. 2919-2922, (1990)
[10]  
Miller, Burton, Karwande, Et al., Early, aggressive open lung biopsy in heart-transplant recipients, J Heart Transplant, 6, pp. 96-99, (1987)